Literature DB >> 1384694

RNA binding assays for Tat-derived peptides: implications for specificity.

K M Weeks1, D M Crothers.   

Abstract

RNA recognition by the HIV Tat protein is mediated in part by an arginine- and lysine-rich basic subdomain implicated as a signature element in proteins that bind RNA. Relative RNA binding affinities for a 14-residue peptide derived from Tat that spans the basic region are determined using a competition protocol. Binding specificity is compared with complexation by a 38-residue model for the RNA binding domain of Tat using the same approach. Binding strength for the minimal (14 residue) peptide is correlated with that for the longer peptide: both peptides recognize a short, bulged duplex. However, the shorter peptide dissociates more rapidly from the wild-type site and discriminates less well between nonspecific (double-stranded RNA) and specific sites. Relative dissociation constants for 38-residue peptide determined from direct partition and competition assays differ; the former assay consistently predicts stronger discrimination against RNAs with mutations in the stems flanking the bulge. Differences between the two assays are reconciled in terms of contributions from labile binding which is unstable to native gel electrophoresis. Kinetic stability may constitute a major specificity determinant for basic subdomain-mediated recognition of RNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384694     DOI: 10.1021/bi00157a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication.

Authors:  W Li; Y Li; N Kedersha; P Anderson; M Emara; K M Swiderek; G T Moreno; M A Brinton
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Purifying mRNAs with a high-affinity eIF4E mutant identifies the short 3' poly(A) end phenotype.

Authors:  Youkyung Hwang Choi; Curt H Hagedorn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

3.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Splicing factor hSlu7 contains a unique functional domain required to retain the protein within the nucleus.

Authors:  Noam Shomron; Mika Reznik; Gil Ast
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

5.  Ionic interactions between PRNA and P protein in Bacillus subtilis RNase P characterized using a magnetocapture-based assay.

Authors:  Jeremy J Day-Storms; S Niranjanakumari; Carol A Fierke
Journal:  RNA       Date:  2004-08-30       Impact factor: 4.942

6.  Evidence for a base triple in the free HIV-1 TAR RNA.

Authors:  Hendrik Huthoff; Frederic Girard; Sybren S Wijmenga; Ben Berkhout
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

7.  Interactions of protein side chains with RNA defined with REDOR solid state NMR.

Authors:  Wei Huang; Gabriele Varani; Gary P Drobny
Journal:  J Biomol NMR       Date:  2011-09-25       Impact factor: 2.835

8.  Isolated CP1 domain of Escherichia coli leucyl-tRNA synthetase is dependent on flanking hinge motifs for amino acid editing activity.

Authors:  Aswini K Betha; Amy M Williams; Susan A Martinis
Journal:  Biochemistry       Date:  2007-05-03       Impact factor: 3.162

9.  Human eukaryotic initiation factor 4G (eIF4G) protein binds to eIF3c, -d, and -e to promote mRNA recruitment to the ribosome.

Authors:  Nancy Villa; Angelie Do; John W B Hershey; Christopher S Fraser
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

10.  Footprinting RNA-protein complexes following gel retardation assays: application to the R-17-procoat-RNA and tat--TAR interactions.

Authors:  L Pearson; C B Chen; R P Gaynor; D S Sigman
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.